🇺🇸 Midazolam HCI in United States

5 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 23 April 2025 – 23 April 2026
• Total reports: 5

Most-reported reactions

1. Drug Ineffective — 2 reports (40%)
2. Circumstance Or Information Capable Of Leading To Medication Error — 1 report (20%)
3. Extra Dose Administered — 1 report (20%)
4. Pharmaceutical Product Complaint — 1 report (20%)

Source database →

Frequently asked questions

Is Midazolam HCI approved in United States?

Midazolam HCI does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Midazolam HCI in United States?

Eisai Inc. is the originator. The local marketing authorisation holder may differ — check the official source linked above.